Obesity

Long-Term Health Care Utilization Costs of GLP-1RA Use vs Bariatric Metabolic Surgery

JAMA Netw OpenPublished Retrospective cohort study

Main finding · Monthly follow-up health care costsResult — go to the resultAdjusted difference-in-differences $109.0 monthly costs per patient

Authors' conclusion

This cohort study found that, among adults with obesity and diabetes, health care utilization costs were higher with GLP-1RA treatment than with BMS, excluding intervention costs, largely reflecting differences in early clinical trajectories.

Study context

Population
Adults (aged ≥24 years) with obesity (BMI ≥30) and diabetes, first bariatric metabolic surgery (BMS) or GLP-1 RA initiation 2010–2022, Clalit Health Services, Israel; mean age 51 years, 59.6% women, mean BMI 40.5
Participants
5,442 adults2,721 matched pairs
Exposure
GLP-1 RA treatment vs BMS
  • GLP-1RAn = 2,721
  • BMSn = 2,721reference
Outcome
Health care utilization costs incurred by the health system, excluding costs of the index interventions; attributable costs by difference-in-differences, multivariable linear regression
Follow-up
Up to 12.5 years (mean [SD], 6.5 [3.5] years)
Methodological detailsobservational, propensity score matched
  • Observational
  • Propensity score matched

Main finding

Monthly follow-up health care costs

Adjusted difference-in-differences

$109.0 monthly costs per patient

P < 0.001

By group

GLP-1RAs

$415.3

mean · SD $746.7

BMS

$304.9

mean · SD $628.5

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeAdjusted difference-in-differencesP value
Hospitalization costs (component of adjusted monthly cost difference)GLP-1RAs vs BMS · SE = $13.3$43.9P = 0.001
Non-GLP-1 medication costs (component of adjusted monthly cost difference)GLP-1RAs vs BMS · SE = $4.4$52.5P < 0.001

Timing of cost differences

Most cost differences accrued within the first 4 years

BMI and HbA1c

BMS associated with greater early reductions in BMI and HbA1c; GLP-1 RA showed more modest but sustained effects

Original publication

Long-Term Health Care Utilization Costs of GLP-1RA Use vs Bariatric Metabolic Surgery. JAMA Netw Open. Published 1 July 2026. doi:10.1001/jamanetworkopen.2026.21305

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.